Llew Keltner, Director at Raptor Pharmaceutical Corp (RPTP), sold 10,000 shares at $14.01 ($140K) on 2013-11-07, disclosed to the SEC on 2013-11-12.
Scheduled sale ($140k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.01 | 9,500 | $133K | 94.7% |
| 2 | $14.80 | 500 | $7K | 5.3% |
| Total | $14.05 avg | 10,000 | $140K | 100% |
| Filing → |
| RPTP | BUY | 2014-06-03 | $837 | — | Filing → |
| RPTP | SELL | 2014-03-11 | $157K | — | Filing → |
| RPTP | SELL | 2014-01-09 | $133K | — | Filing → |